tiprankstipranks
Adverum Biotechnologies (GB:0HA3)
LSE:0HA3

Adverum Biotechnologies (0HA3) Financial Statements

1 Followers

Adverum Biotechnologies Financial Overview

Adverum Biotechnologies's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Adverum Biotechnologies is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-1.41. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue---$ 3.60M-
Gross Profit--$ 1.40M$ 3.60M$ 4.10M
EBIT$ -24.85M$ -32.87M$ -31.49M$ -29.04M$ -33.94M
EBITDA$ -23.38M$ -25.99M$ -25.16M$ -26.98M$ -32.83M
Net Income Common Stockholders$ -24.72M$ -32.82M$ -31.51M$ -29.06M$ -32.34M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 96.53M$ 117.08M$ 141.45M$ 164.28M$ 185.59M
Total Assets$ 173.01M$ 196.77M$ 241.43M$ 275.58M$ 308.37M
Total Debt$ 75.04M$ 75.52M$ 91.15M$ 97.61M$ 106.80M
Net Debt$ -21.49M$ -41.56M$ -50.30M$ -66.67M$ -78.79M
Total Liabilities$ 89.54M$ 94.06M$ 110.27M$ 117.82M$ 126.85M
Stockholders Equity$ 83.47M$ 102.71M$ 131.13M$ 157.76M$ 181.52M
Cash Flow-
Free Cash Flow$ -21.52M$ -24.41M$ -23.29M$ 2.50M-
Operating Cash Flow$ -21.33M$ -23.91M$ -23.25M$ 2.50M-
Investing Cash Flow$ -9.88M$ 18.20M$ 67.02M$ 21.53M-
Financing Cash Flow$ 166.00K$ -105.00K$ 8.00K--
Currency in USD

Adverum Biotechnologies Earnings and Revenue History

Adverum Biotechnologies Debt to Assets

Adverum Biotechnologies Cash Flow

Adverum Biotechnologies Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis